Total Payments
$985.94
2024 Payments
$127.76
Companies
20
Transactions
58
Medicare Patients
223
Medicare Billing
$23,986
Payment Breakdown by Category
Food & Beverage$985.94 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $985.94 | 58 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $207.78 | 13 | $0 (2022) |
| PFIZER INC. | $195.58 | 12 | $0 (2024) |
| AbbVie Inc. | $92.08 | 5 | $0 (2023) |
| Allergan, Inc. | $66.56 | 5 | $0 (2020) |
| Alkermes, Inc. | $54.76 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $50.87 | 3 | $0 (2022) |
| Xeris Pharmaceuticals, Inc. | $48.45 | 2 | $0 (2024) |
| Eisai Inc. | $39.75 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $32.94 | 2 | $0 (2022) |
| Ethicon US, LLC | $26.99 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $127.76 | 5 | Xeris Pharmaceuticals, Inc. ($48.45) |
| 2023 | $97.19 | 6 | PFIZER INC. ($33.14) |
| 2022 | $289.22 | 16 | PFIZER INC. ($84.10) |
| 2021 | $14.89 | 1 | Novo Nordisk Inc ($14.89) |
| 2020 | $26.78 | 2 | Allergan, Inc. ($26.78) |
| 2019 | $173.82 | 10 | Novo Nordisk Inc ($54.42) |
| 2018 | $183.88 | 13 | Novo Nordisk Inc ($48.91) |
| 2017 | $72.40 | 5 | Novo Nordisk Inc ($36.64) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $39.75 | General |
| Category: Neurology | ||||||
| 07/18/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 05/23/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 05/14/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: WOMENS HEALTH | ||||||
| 01/09/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: CNS | ||||||
| 12/04/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Oncology | ||||||
| 05/24/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Diabetes | ||||||
| 05/10/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/13/2023 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Endocrinology | ||||||
| 03/23/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/15/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/29/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/13/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/05/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Diabetes | ||||||
| 09/15/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: RESPIRATORY | ||||||
| 08/18/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/11/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.66 | General |
| 07/14/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/29/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/02/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Diabetes | ||||||
| 05/24/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/19/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/14/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 35 | 40 | $12,865 | $3,231 |
| 2022 | 4 | 71 | 102 | $28,778 | $8,343 |
| 2021 | 4 | 63 | 86 | $24,193 | $7,371 |
| 2020 | 4 | 54 | 62 | $15,887 | $5,042 |
Total Patients
223
Total Services
290
Medicare Billing
$23,986
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $6,715 | $1,525 | 22.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 17 | $3,516 | $1,031 | 29.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 11 | $2,633 | $675.07 | 25.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 21 | $10,966 | $3,052 | 27.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 28 | $7,092 | $2,152 | 30.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 36 | $6,343 | $1,861 | 29.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 16 | 17 | $4,377 | $1,278 | 29.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 18 | $8,789 | $2,428 | 27.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 29 | $7,117 | $2,324 | 32.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 15 | 17 | $4,301 | $1,391 | 32.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 22 | $3,986 | $1,228 | 30.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 13 | $6,082 | $2,079 | 34.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 16 | 17 | $4,140 | $1,423 | 34.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 20 | $3,309 | $1,138 | 34.4% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 11 | 12 | $2,357 | $401.97 | 17.1% |
About Dr. Andrew Berardinelli, MD
Dr. Andrew Berardinelli, MD is a Family Medicine healthcare provider based in Grafton, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2014. The National Provider Identifier (NPI) number assigned to this provider is 1730591124.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Berardinelli, MD has received a total of $985.94 in payments from pharmaceutical and medical device companies, with $127.76 received in 2024. These payments were reported across 58 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($985.94).
As a Medicare-enrolled provider, Berardinelli has provided services to 223 Medicare beneficiaries, totaling 290 services with total Medicare billing of $23,986. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Grafton, WV
- Active Since 05/20/2014
- Last Updated 12/09/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1730591124
Products in Payments
- DALVANCE (Drug) $119.47
- ELIQUIS (Drug) $117.24
- PREVNAR 13 (Biological) $63.48
- Ozempic (Drug) $59.31
- Tresiba (Drug) $51.12
- KEVEYIS (Drug) $48.45
- VIVITROL (Drug) $42.83
- Leqembi (Drug) $39.75
- Levemir (Drug) $36.99
- ENTRESTO (Drug) $32.94
- LINX Reflux Management System (Device) $26.99
- NUEDEXTA (Drug) $23.14
- Victoza (Drug) $23.07
- STIOLTO RESPIMAT (Drug) $22.77
- QULIPTA (Drug) $22.72
- t:slim X2 Insulin Pump with Control-IQ (Device) $17.06
- MOUNJARO (Drug) $16.99
- TEFLARO (Drug) $16.45
- Cologuard Collection Kit (Device) $16.28
- SPIRIVA RESPIMAT (Drug) $16.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Grafton
Gloria Jackson, M.d, M.D
Family Medicine — Payments: $5,395
Family Medicine $5,395
John Hollingsworth, M.d, M.D
Family Medicine — Payments: $2,211
Family Medicine $2,211
Dr. Michael Hess, M.d, M.D
Family Medicine — Payments: $2,186
Family Medicine $2,186
Dr. Jennifer Shaw, M.d, M.D
Family Medicine — Payments: $2,164
Family Medicine $2,164
Mr. Gregory Selasky, Ms, P.a.-C, MS, P.A.-C
Family Medicine — Payments: $1,974
Family Medicine $1,974
David Bender, Md, MD
Family Medicine — Payments: $1,676
Family Medicine $1,676